COVID-19 in IBD: The experience of a single tertiary IBD center.

ABSTRACT:

Background

Italy has been one of the most affected countries in the world by COVID-19. There has been increasing concern regarding the impact of COVID-19 on patients with inflammatory bowel disease (IBD), particularly in patients treated with immunosuppressants or biologics. The aim of our study is to understand the incidence of COVID-19 in a large cohort of patients with IBD. Furthermore, we analyzed possible risk factors for infection and severity of COVID-19.

Methods

This was an observational study evaluating the impact of COVID-19 on IBD patients in a single tertiary center. A 23 multiple-choice-question anonymous survey was administered to 1200 patients with IBD between March 10th and June 10th 2020.

Results

1158 questionnaires were analyzed. The majority of pati

SUBMITTER: Rizzello F 

PROVIDER: S-EPMC7764386 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature